Original news and analysis on international IP policy
The UN World Health Organization this week clarified that the possibility exists for the WHO Executive Board to discuss a recently released report from a UN Secretary General-appointed panel that makes recommendations for improving global access to medicines.
As 16 Asia and Pacific nations prepare to meet in Indonesia next week for the next round of negotiations for a large regional trade agreement called RCEP, more than 300 civil society groups signed a letter urging negotiators to reject efforts to bring in texts from the separate Trans-Pacific Partnership (TPP).
The Staff Association of the Geneva-based European Organization for Nuclear Research (CERN) this week issued a strongly worded statement in solidarity with staff at the European Patent Office. They called the EPO essential to Europe and said the EPO president's repressive "19th century"-style anti-worker tactics are endangering the institution and the European economy.
United Nations Secretary-General Ban Ki-moon today issued a message praising the "milestone" report of a High-Level Panel on access to medicines he set up a year ago to address the continuing problem of medicines prices being too high for many in the world to afford, and the lack of access to quality medicines for many. In his message, he called on governments to review the report and its recommendations, and to chart a way forward to address the problem of lack of access to medicines and health technologies.
With the recent entry into force of the Marrakesh Treaty providing copyright exceptions for persons with visual impairments, a panel convened alongside last week's World Intellectual Property Organization copyright committee meeting explored ways to transform the treaty’s promises into reality.
Governments around the world are increasingly cracking down on use of communications apps like WhatsApp and Facebook. Of the 65 countries assessed, governments in 24 impeded access to social media and communication tools, up from 15 in the previous year, the report said.
The German constitutional court has rebuffed a second complaint seeking to allow oversight bodies to see the US National Security Administration (NSA) selector list.
The Access to Medicine Index 2016 was published today, analysing the top 20 research-based pharmaceutical companies. The index looks at how those companies make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. The index found progress in companies' efforts to improve access but little support for flexibilities enshrined in international trade rules.
The World Trade Organization intellectual property committee this week discussed the report of United Nations Secretary General’s High-Level Panel on access to medicines which offered recommendations regarding the use of intellectual property in international trade. Developing countries taking the floor accentuated the use of flexibilities under trade rules, and the World Health Organization gave an overview of how its activities follow the panel's recommendations, and its future projects. Civil society meanwhile criticised the WHO’s decision to dismiss a request by some developing countries to include discussions on the UN report at the next Executive Board Meeting.
The European Commission has issued its opinion on certain articles of the EU directive on biotechnological inventions, in particular the patentability of plants or animals obtained as a result of natural occurrence such as selection and crossing. The Commission found that the intention of the EU when drafting the legislation was to exclude such products from patentability.
Countries of the world decided in 2015 to launch an ambitious agenda to end poverty, protect the planet, and ensure prosperity for all by 2030. What should be the role of the UN World Intellectual Property Organization in the attainment of the adopted United Nations Sustainable Development Goals? This question, discussed at the WIPO Committee on Development and IP, is dividing countries, as developed countries argue that only a few goals apply to the work of WIPO, and others argue that there should be no ‘cherrypicking’ as all the goals in one way or another do apply to WIPO's work as a UN agency.
While the issue of antimicrobial resistance has arrived in high-level discussions, and there is a consensus that the problem must be tackled one way or another to avoid slipping back into a pre-antibiotic era, some voices are highlighting the need to remember that other health issues remain unmet, and access to medicines is still an acute problem.